Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.65 USD | +0.61% | -11.76% | -43.69% |
Apr. 11 | BTIG Starts Carisma Therapeutics With Buy Rating, $6 Price Target | MT |
Apr. 02 | HC Wainwright Adjusts Price Target on Carisma Therapeutics to $9 From $11, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.69% | 68.13M | |
-2.74% | 103B | |
+1.53% | 95.28B | |
+1.46% | 22.15B | |
-15.61% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.90% | 16.05B | |
+5.36% | 13.68B | |
+33.69% | 12.17B |
- Stock Market
- Equities
- CARM Stock
- News Carisma Therapeutics, Inc.
- Carisma Therapeutics Q4 Net Loss Narrows, Revenue Rises; Plans Job Cuts in Q2 -- Shares Decline